These Xrcc5 knock-out mice exhibit growth deficiency including decreased size of spleen, lymph nodes and thymus with curtailed T cell and B cell development.
Andre Nussenzweig, CCR, NCI, National Institutes of Health
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Xrcc5 | X-ray repair complementing defective repair in Chinese hamster cells 5 |
Mice that are homozygous for the targeted mutation are viable, fertile, but are 40-60% the size of normal mice. No Xrcc5 protein product is detected. The growth deficiency phenotype is exhibited as early as E15.5. Organ weights, excepting lymphoid organs, are proportional to total body weight. Histological analysis shows decreased size of spleen, lymph nodes and thymus. T cell and B cell development is arrested at early precursor stages and a deficiency in V(D)J rearrangement is exhibited. B cell maturation stops at the B220+CD43+ stage. Only CD4-CD8- cells are found in the thymus. Primary embryonic fibroblasts (MEFs) have slower growth and early loss of proliferating cells. Early appearance of non-dividing cells in MEF cultures suggest early onset senescence. Karyotypes reveal increased chromosomal aberrations. Breaks or translocations occur in 83% of metaphases, polyploidy in 15%. Although cells from the mutant mice display chromosomal instability, these mice do not display early tumorigenesis. Litters must be fostered because homozygous mutant female mice are unable to sustain newborn pups. Survival of homozygous mutant mice is 80% when the larger heterozygous mutant and wildtype littermates are removed. This mutant mouse strain represents a model that may be useful in studies related to DNA repair and aging.
A targeting vector containing a neomycin resistance gene driven by the phosphoglycerate kinase promoter was used to disrupt 3.4 kb of the targeted gene, including 100 bp of the promoter and first 2 exons. The construct was electroporated into 129 derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were backcrossed to C57BL/6 mice.
Allele Name | targeted mutation 1, Andre Nussenzweig |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | Ku80-; Ku86-; Xrcc5tm1Gcl |
Gene Symbol and Name | Xrcc5, X-ray repair complementing defective repair in Chinese hamster cells 5 |
Gene Synonym(s) | |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | 1 |
Molecular Note | A neomycin resistance cassette replaced 3.4 kb of the gene, including 100 bp of the promoter region. |
Mutations Made By | Andre Nussenzweig, CCR, NCI, National Institutes of Health |
This strain originated on a B6;129 background, has been backcrossed for 9 generations on the C57BL/6 background and is maintained as a heterozygote.
When using the Ku80- mouse strain in a publication, please cite the originating article(s) and include JAX stock #004361 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Xrcc5<tm1Nus> |
Frozen Mouse Embryo | B6.129-Xrcc5<tm1Nus>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129-Xrcc5<tm1Nus>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129-Xrcc5<tm1Nus>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.129-Xrcc5<tm1Nus>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.